NEW YORK (GenomeWeb News) — Rules-Based Medicine has won a grant from the National Cancer Institute to work with Correlogic Systems to develop biomarker panels for cancer detection, RBM said today.
 
The contract includes a Phase I fast-track component and a Phase II option that together amount to $1.15 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.